-

American Vanguard Announces Date of Fourth Quarter 2024 Earnings Release and Webcast Conference Call

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--American Vanguard® Company (NYSE: AVD) announced today it will release financial results for the fourth quarter of 2024 on Friday, March 14, 2025, before the market opens.

The company will conduct a conference call focusing on operating performance and financial results at 9:00 a.m. ET / 6:00 a.m. PT on Friday, March 14, 2025. The conference call will be webcast live via, available in the News and Media section of the Company’s website at www.american-vanguard.com or through the following link: https://www.webcaster4.com/Webcast/Page/3070/52044

If you are unable to listen live, the conference call will be archived on the Company’s website: www.american-vanguard.com/investors

About American Vanguard
American Vanguard Corporation (AVD) is a diversified specialty and agriculture products company that develops and markets products for crop protection and management, turf and ornamentals management, and public and animal health. Over the past 20 years, through product and business acquisitions, the Company has expanded its operations into 21 countries and now has more than 1,000 product registrations in 56 nations, worldwide. To learn more about the Company, please reference www.american-vanguard.com.

The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in this release, all forward-looking statements are estimates by the Company’s management and are subject to various risks and uncertainties that may cause results to differ from management’s current expectations. Such factors include weather conditions, changes in regulatory policy and other risks as detailed from time-to-time in the Company’s SEC reports and filings. All forward-looking statements, if any, in this release represent the Company’s judgment as of the date of this release.

Contacts

Company Contact
American Vanguard Corporation
Anthony Young, Director of Investor Relations
anthonyy@amvac.com
(949) 221-6119

Investor Representative
Alpha IR Group
Robert Winters
Robert.winters@alpha-ir.com
(929) 266-6315

American Vanguard Company

NYSE:AVD

Release Versions

Contacts

Company Contact
American Vanguard Corporation
Anthony Young, Director of Investor Relations
anthonyy@amvac.com
(949) 221-6119

Investor Representative
Alpha IR Group
Robert Winters
Robert.winters@alpha-ir.com
(929) 266-6315

More News From American Vanguard Company

American Vanguard Receives NYSE Notice Regarding Delayed 10-K Filing

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--On April 2, 2025 American Vanguard (NYSE: AVD) (the “Company”) received notice from the New York Stock Exchange (the “NYSE”) that the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual due to a delay in filing its Annual Report on Form 10-K for the year ended December 31, 2024, with the Securities and Exchange Commission (the “SEC”). The Company determined it would not be able to file the Form 10-K within the 15-day extens...

American Vanguard Reports Preliminary Results for Fourth Quarter & Full Year 2024

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--American Vanguard® Corporation (NYSE:AVD), a diversified specialty and agricultural products company that develops, manufactures, and markets solutions for crop protection and nutrition, turf and ornamental management and commercial pest control, today reported preliminary, financial results for the fourth quarter and full year ended December 31, 2024. The results reported herein are preliminary. Final results will appear in the company’s 10-K for the fis...

AMVAC®, DPH Biologicals™ Sign Regional Distribution Agreement

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--American Vanguard® Corporation today announced that its crop business unit, AMVAC®, entered into a regional distribution agreement with DPH Biologicals®, a leading developer and supplier of agricultural biologicals. The agreement significantly expands American Vanguard’s GreenSolutions portfolio and increases availability of biological products throughout the U.S. while also expanding DPH Bio’s footprint into specialty crop markets. Under the long-term ag...
Back to Newsroom